Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discharge Readiness After Propofol With or Without Esketamine for Outpatient Flexible Bronchoscopy
NCT05643066Phase 4Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative recovery (3 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Proportions of patients discharged within 30 min after bronchoscopy. Started Dec 2022; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative recovery
Beyond the preview
Go deeper on NCT05643066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05643066.